Early Recognition and Optimal Treatment of Delirium in Patients with Advanced Cancer.
Recruiting
- Conditions
- advanced cancer, delirium
- Registration Number
- NL-OMON21878
- Lead Sponsor
- VU University Medical Center
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 300
Inclusion Criteria
1. Patient has been diagnosed with advanced cancer;
2. Age ≥ 18;
Exclusion Criteria
1. Delirium is due to alcohol withdrawal;
2. Patient has been diagnosed with glaucoma, Parkinson’s disease or dementia;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary endpoint for this trial is a DRS-R-98 severity rating score < 15,2518, as this is a measure for establishing clearance of delirium.<br>
- Secondary Outcome Measures
Name Time Method Secondary endpoint is the amount of time elapsed between start of treatment and diminishing of the signs of delirium (DOS < 3, DSR-R-98 < 15,25).